Ibandronate Sodium Patent Expiration
Ibandronate Sodium is Used for the treatment and prevention of osteoporosis in postmenopausal women. It was first introduced by Hoffmann La Roche Inc
Ibandronate Sodium Patents
Given below is the list of patents protecting Ibandronate Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Boniva | US7192938 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US7410957 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US7718634 | Method of treatment using bisphosphonic acid |
May 06, 2023
(Expired) | Hoffmann La Roche |
| Boniva | US6294196 | Pharmaceutical composition containing diphosphonic acid or salt thereof |
Oct 07, 2019
(Expired) | Hoffmann La Roche |
| Boniva | US6143326 | Oral pharmaceutical preparation containing ibandronat |
Apr 21, 2017
(Expired) | Hoffmann La Roche |
| Boniva | US5662918 | Pharmaceutical agents containing diphosphonic acids and salts thereof |
Sep 02, 2014
(Expired) | Roche |
Ibandronate Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List